Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1317644
PUBLISHER: BCC Research | PRODUCT CODE: 1317644
Artificial Organs: Global Markets
PUBLISHED:
PAGES: 114 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
The global artificial organs market should reach $17.7 billion by 2028 from $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 4.2% for the forecast period of 2023 to 2028.
Artificial kidney segment of the global artificial organs market is expected to grow from $5.8 billion in 2023 to $6.8 billion in 2028 at a CAGR of 3.3% for the forecast period of 2023 to 2028.
Artificial heart segment of the global artificial organs market is expected to grow from $1.4 billion in 2023 to $1.9 billion in 2028 at a CAGR of 6.5% for the forecast period of 2023 to 2028.
Report Scope:
This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).
This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.
This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.
Report Includes:
- 28 data tables and 14 additional tables
- An overview of the global artificial organs market
- Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
- Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
- Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
- Insights into R&D investments, government growth-promoting policies, rules, and regulations
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
- Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova
Product Code: MDS091A
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology
- Information Sources
- Primary Research
- Secondary Research
- Geographic Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Artificial Organs Market
Chapter 3 Market Overview and Definitions
- Overview
- Artificial Organs
Chapter 4 Market Trends
- Market Drivers
- Aging Population
- Diabetic Cases by Countries
- Chronic Kidney Disease Cases by Countries
- Penetration of Artificial Organs in Emerging Markets
- Market Opportunity
- Market Restraints
Chapter 5 Market Breakdown by Product Type
- Introduction
- Artificial Heart
- Artificial Kidney
- Artificial Lung
- Artificial Pancreas
- Cochlear Implant
Chapter 6 COVID-19 Impact Analysis
- Introduction
- COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
- Decline/Delay in Elective Procedures
- Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
- COVID-19 Impact on Artificial Organs Markets
Chapter 7 Market Breakdown by Region
- Market Overview and Discussion
- North America
- U.S.
- Canada
- Mexico
- Latin America
- Brazil
- Argentina
- Chile
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Chapter 8 Competitive Landscape
- Industry Scenario
- Company Shares
Chapter 9 Emerging/Upcoming Technologies
- Key/Emerging Technologies/Trends in the Market
- Tissue Engineering and Regenerative Medicine
- Organ-on-a-Chip
- Bio-fabrication and 3D Bioprinting
- Biomaterials and Biocompatible Materials
- Immunomodulation and Immunotolerance Strategies
- Neural Interfaces and Brain-Machine Interfaces
- Gene Editing and Gene Therapy
Chapter 10 M&A and Fundings Outlook
- M&A Analysis
- SynCardia System's Acquisition by Versa Capital Management
- Abiomed's Acquisition of Berlin Heart
- LivaNova's Acquisition of TandemLife
- Fresenius Medical Care's Acquisition of NxStage Medical
- B. Braun's Acquisition of NxStage Medical's Bloodlines Business
- LivaNova's Acquisition of TandemLife
- Cantel Medical's Acquisition of hemodialysis business from Gambro
- Eli Lilly's Acquisition of Protomer Technologies
- Johnson & Johnson Acquisition of Abiomed Inc.
Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective
- Introduction
- Environmental Factors
- Social Factors
- Governance Factors
- Artificial Organs Market: ESG Performance Analysis, by Company
- Conclusion
Chapter 12 Patent Analysis
- Patent Analysis by Manufacturer
Chapter 13 Pipeline Analysis
- Clinical Trials Scenario
Chapter 14 Company Profiles
- ABIOMED
- ABBOTT
- BAXTER INTERNATIONAL INC.
- B. BRAUN SE
- COCHLEAR LTD.
- FRESENIUS MEDICAL CARE AG & CO. KGAA
- F. HOFFMANN-LA ROCHE AG
- GETINGE AB
- INSULET CORP.
- LIVANOVA PLC
- MEDTRONIC
- MED-EL MEDICAL ELECTRONICS
- NIPRO CORP.
- SONOVA
- TERUMO CORP.
- TANDEM DIABETES CARE, INC.
- YPSOMED AG
Product Code: MDS091A
List of Tables
- Summary Table : Global Market for Artificial Organs, by Product Type, Through 2028
- Table 1 : Global Population, Aged 60 and Older, 2010-2050
- Table 2 : Diabetic Cases, by Country, 2000-2045
- Table 3 : Chronic Kidney Disease Cases, by Country, 2017-2023
- Table 4 : Global Market for Artificial Organs, by Product Type, Through 2028
- Table 5 : Global Market for Artificial Hearts, by Region, Through 2028
- Table 6 : Global Market for Artificial Kidneys, by Region, Through 2028
- Table 7 : Global Market for Artificial Lungs, by Region, Through 2028
- Table 8 : Global Market for Artificial Pancreases, by Region, Through 2028
- Table 9 : Global Market for Cochlear Implants, by Region, Through 2028
- Table 10 : Global Market for Artificial Organs, by Region, Through 2028
- Table 11 : North American Market for Artificial Organs, by Country, Through 2028
- Table 12 : Latin American Market for Artificial Organs, by Country, Through 2028
- Table 13 : European Market for Artificial Organs, by Country, Through 2028
- Table 14 : Asia-Pacific Market for Artificial Organs, by Country, Through 2028
- Table 15 : RoW Market for Artificial Organs, Through 2028
- Table 16 : Medtronic ESG Performance
- Table 17 : Abbott ESG Performance
- Table 18 : Cochlear Ltd. ESG Performance
- Table 19 : Artificial Heart Patents, by Organization, 2019-2022
- Table 20 : Artificial Kidney Patents, by Organization, 2019-2022
- Table 21 : Artificial Lung Patents, by Organization, 2019-2022
- Table 22 : Artificial Pancreas, by Organization, 2019-2022
- Table 23 : Cochlear Implants, by Organization, 2019-2022
- Table 24 : Selected Artificial Heart Devices in Clinical Trials, 2023
- Table 25 : Selected Artificial Kidney Devices in Clinical Trials, 2023
- Table 26 : Selected Artificial Lung Devices in Clinical Trials, 2023
- Table 27 : Selected Artificial Pancreas in Clinical Trials, 2023
- Table 28 : Selected Cochlear Implants in Clinical Trials, as of 2023
- Table 29 : Abbott: Revenue, by Segment, 2020-2022
- Table 30 : Abbott: Revenue, by Region, 2020-2022
- Table 31 : Baxter International Inc.: Revenue, by Segment, 2020-2022
- Table 32 : Baxter International Inc.: Revenue, by Region, 2021 and 2022
- Table 33 : F. Hoffmann-La Roche Ltd.: Financials, 2020-2022
- Table 34 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2020-2022
- Table 35 : Getinge AB: Revenue, by Segment, 2020-2022
- Table 36 : Insulet Corp.: Revenue, by Segment, 2020-2022
- Table 37 : LivaNova: Revenue, by Segment, 2020-2022
- Table 38 : Nipro Corp.: Revenue, by Segment, 2020-2022
- Table 39 : Sonova: Revenue, by Segment, 2021 and 2022
- Table 40 : Sonova: Revenue, by Region, 2021 and 2022
- Table 41 : Acronyms Used in This Report
List of Figures
- Summary Figure A : Global Market for Artificial Organs, by Product Type, 2020-2028
- Summary Figure B : Global Market Shares of Artificial Organs, by Product Type, 2022
- Figure 1 : Global Market for Artificial Organs, by Product, 2020-2028
- Figure 2 : Global Market Shares of Artificial Organs, by Product, 2022
- Figure 3 : Global Market for Artificial Hearts, by Region, 2020-2028
- Figure 4 : Global Market Shares of Artificial Hearts, by Region, 2022
- Figure 5 : Global Market for Artificial Kidneys, by Region, 2020-2028
- Figure 6 : Global Market Shares of Artificial Kidneys, by Region, 2022
- Figure 7 : Global Market for Artificial Lungs, by Region, 2020-2028
- Figure 8 : Global Market Shares of Artificial Lungs, by Region, 2022
- Figure 9 : Global Market for Artificial Pancreases, by Region, 2020-2028
- Figure 10 : Global Market Shares of Artificial Pancreases, by Region, 2022
- Figure 11 : Global Market for Cochlear Implants, by Region, 2020-2028
- Figure 12 : Global Market Shares of Cochlear Implants, by Region, 2022
- Figure 13 : Global Market Shares of Artificial Organs, by Region, 2022
- Figure 14 : North American Market Shares of Artificial Organs, by Country, 2022
- Figure 15 : Latin American Market Shares of Artificial Organs, by Country, 2022
- Figure 16 : European Market Shares of Artificial Organs, by Country, 2022
- Figure 17 : Asia-Pacific Market Shares of Artificial Organs, by Country, 2022
- Figure 18 : Global Market Shares of Artificial Organs, by Company, 2022
- Figure 19 : Global Market Shares of Artificial Heart, by Company, 2022
- Figure 20 : Global Market Shares of Artificial Kidney, by Company, 2022
- Figure 21 : Global Market Shares of Artificial Lung, by Company, 2022
- Figure 22 : Global Market Shares of Artificial Pancreas, by Company, 2022
- Figure 23 : Global Market Shares of Cochlear Implants, by Company, 2022
- Figure 24 : Emerging Trends/Technologies in the Artificial Organs Market
- Figure 25 : Abiomed: Company Revenue, 2020-2022
- Figure 26 : Abbott: Company Revenue, 2020-2022
- Figure 27 : Abbott: Revenue Share, by Segment, 2022
- Figure 28 : Abbott: Revenue Share, by Region
- Figure 29 : Baxter International Inc.: Company Revenue, 2020-2022
- Figure 30 : Baxter International Inc.: Revenue Share, by Segment, 2022
- Figure 31 : B. Braun: Company Revenue, 2020-2022
- Figure 32 : Cochlear: Implant Sales, 2020-2022
- Figure 33 : Fresenius Medical Care: Revenue, 2020-2022
- Figure 34 : Getinge AB: Company Revenue, 2020-2022
- Figure 35 : Insulet Corp.: Company Revenue, 2020-2022
- Figure 36 : LivaNova: Company Revenue, 2020-2022
- Figure 37 : Medtronic: Company Revenue, 2020-2022
- Figure 38 : Nipro Corp.: Company Revenue, 2020-2022
- Figure 39 : Nipro Corp.: Revenue Share, by Segment, 2022
- Figure 40 : Nipro Corp.: Revenue Share, by Region/Country, 2022
- Figure 41 : Sonova: Company Revenue, 2021 and 2022
- Figure 42 : Sonova: Revenue Share, by Segment, 2022
- Figure 43 : Sonova: Revenue Share, by Region, 2022
- Figure 44 : Tandem Diabetes Care: Company Revenue, 2020-2022
- Figure 45 : Ypsomed: Company Revenue, 2020-2022
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.